KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $873,248 | -0.9% | 7,528 | +0.3% | 0.01% | +8.3% |
| Q2 2023 | $880,852 | +95.5% | 7,503 | +33.3% | 0.01% | +71.4% |
| Q1 2023 | $450,498 | -13.5% | 5,627 | -16.9% | 0.01% | +133.3% |
| Q1 2021 | $521,000 | +28.0% | 6,769 | -0.2% | 0.00% | +50.0% |
| Q4 2020 | $407,000 | +32.1% | 6,783 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $308,000 | +0.3% | 7,146 | -3.7% | 0.00% | 0.0% |
| Q2 2020 | $307,000 | +15250.0% | 7,421 | +19956.8% | 0.00% | – |
| Q1 2020 | $2,000 | +100.0% | 37 | +68.2% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |